Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP897998.RAStdJ8zpCCbP91de9cchdO5UmAiZtMRPRbY4n9GRpJEk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP897998.RAStdJ8zpCCbP91de9cchdO5UmAiZtMRPRbY4n9GRpJEk130_assertion type Assertion NP897998.RAStdJ8zpCCbP91de9cchdO5UmAiZtMRPRbY4n9GRpJEk130_head.
- NP897998.RAStdJ8zpCCbP91de9cchdO5UmAiZtMRPRbY4n9GRpJEk130_assertion description "[Moreover, co-treatment with ATM and vincristine (VCR), a microtubule inhibitor currently used in rhabdomyosarcoma treatment regimens, resulted in a combination index of 0.470-0.793 through cooperative accumulation of non-proliferative multinuclear cells in the G2/M phase, indicating that these two drugs synergize.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897998.RAStdJ8zpCCbP91de9cchdO5UmAiZtMRPRbY4n9GRpJEk130_provenance.
- NP897998.RAStdJ8zpCCbP91de9cchdO5UmAiZtMRPRbY4n9GRpJEk130_assertion evidence source_evidence_literature NP897998.RAStdJ8zpCCbP91de9cchdO5UmAiZtMRPRbY4n9GRpJEk130_provenance.
- NP897998.RAStdJ8zpCCbP91de9cchdO5UmAiZtMRPRbY4n9GRpJEk130_assertion SIO_000772 22349825 NP897998.RAStdJ8zpCCbP91de9cchdO5UmAiZtMRPRbY4n9GRpJEk130_provenance.
- NP897998.RAStdJ8zpCCbP91de9cchdO5UmAiZtMRPRbY4n9GRpJEk130_assertion wasDerivedFrom befree-20140225 NP897998.RAStdJ8zpCCbP91de9cchdO5UmAiZtMRPRbY4n9GRpJEk130_provenance.
- NP897998.RAStdJ8zpCCbP91de9cchdO5UmAiZtMRPRbY4n9GRpJEk130_assertion wasGeneratedBy ECO_0000203 NP897998.RAStdJ8zpCCbP91de9cchdO5UmAiZtMRPRbY4n9GRpJEk130_provenance.